Trilogy Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.26M | Buy |
4,187
+2,963
| +242% | +$2.31M | 0.16% | 94 |
|
|
2025
Q1 | $1.01M | Sell |
1,224
-59
| -5% | -$48.7K | 0.05% | 173 |
|
|
2024
Q4 | $991K | Sell |
1,283
-64
| -5% | -$49.4K | 0.05% | 178 |
|
|
2024
Q3 | $1.19M | Buy |
1,347
+51
| +4% | +$45.2K | 0.06% | 168 |
|
|
2024
Q2 | $1.17M | Buy |
1,296
+900
| +227% | +$815K | 0.06% | 161 |
|
|
2024
Q1 | $308K | Buy |
+396
| New | +$308K | 0.02% | 250 |
|
|
2018
Q4 | – | Sell |
-47
| Closed | -$5K | – | 384 |
|
|
2018
Q3 | $5K | Hold |
47
| – | – | ﹤0.01% | 402 |
|
|
2018
Q2 | $4K | Hold |
47
| – | – | ﹤0.01% | 392 |
|
|
2018
Q1 | $4K | Buy |
+47
| New | +$4K | ﹤0.01% | 330 |
|